MedTrace Logo

Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

NCT05525390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-09-22

No results posted yet for this study

Summary

The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive extended reality (XR) headset to engage in behavioral activation (BA) for individuals diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the efficacy of using XR to enhance BA therapy in a clinical MDD population.

Conditions

Interventions

BEHAVIORAL

Extended Reality-Enhanced Behavioral Activation

Participants will choose at least four "activities" to complete in Oculus extended reality over the course of the week. These activities are chosen from the Oculus and may include video 360, social interactions, gaming, etc.

BEHAVIORAL

Traditional Behavioral Activation

Participants will choose at least four pleasurable and/or mastery activities to complete over the course of the week in real life.

Sponsors & Collaborators

Principal Investigators

  • Margot D Paul, Psy.D. · Stanford University

  • Kim Bullock, M.D. · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-19
Primary Completion
2023-07-24
Completion
2023-07-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05525390 on ClinicalTrials.gov